Systematic video-assisted mediastinoscopic lymphadenectomy in the treatment of resectable non-small cell lung cancer
10.3760/cma.j.issn.1001-4497.2013.06.017
- VernacularTitle:电视纵隔镜在可切除非小细胞肺癌术前系统性纵隔淋巴结切除中的应用
- Author:
Ke MA
;
Xiang WANG
;
Tianpeng XIE
;
Xiaojun YANG
;
Ping XIAO
;
Xiang ZHUANG
;
Qiang LI
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small-cell lung;
Mediastinoscopy;
Lymph node excision
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2013;(6):377-379
- CountryChina
- Language:Chinese
-
Abstract:
Objective This study was performed to assess the clinical feasibility of video-assisted mediastinoscopic lymphadenectomy in the treatment of resectable lung cancer.Methods Between March 2011 and May 2012,we retrospectively analyzed the data from 56 patients who underwent video-assisted mediastinoscopic lymphadenectomy(VAMLA).In patients receiving tumour resection subsequently,radicality of the previous mediastinoscopic dissection was controlled during thoracotomy.Results Mean operative time of video-assisted mediastinoscopic lymphadenectomy was(42.0 ± 13.5) min(range of 26-86 min).Mean number of resected lymph nodes was 12.4 ± 6.7 (range of 5-24).In video-assisted mediastinoscopic lymphadenectomy,the rates of lymph node dissection of stations 2,4,5,7,8 were 54.5％,92.7％,58.2％,100％,61.8％,respectively,there was no operative mortality and morbility.90.9％ patients achieved radical dissection.Conclusion Video-assisted mediastinoscopic lymphadenectomy is a clinically feasible procedure and provides more accurate staging of mediastinal node in lung cancer patients.It also plays an important role in minimal invasive surgery and neoadjuvant therapy.
